To apply eye drops, wash your hands first. To avoid contamination, do not touch the dropper tip or let it touch your eye or any other surface. Use in the eyes only. Do not swallow or inject. Show Do not wear contact lenses while you are using this medication. Sterilize contact lenses according to the manufacturer's directions, and check with your doctor before you begin using them again. Tilt your head back, look upward, and pull down the lower eyelid to make a pouch. Hold the dropper directly over your eye and place one drop into the pouch as directed by your doctor. Look downward, gently close your eyes, and place one finger at the corner of your eye (near the nose). Apply gentle pressure for 1 to 2 minutes before opening your eyes. This will prevent the medication from draining out. Try not to blink or rub your eye. Repeat these steps if your dose is for more than one drop. If directed to use this medication in both eyes, repeat these steps for your other eye. Wait several minutes for your vision to clear before driving or operating machinery. Do not rinse the dropper. Replace the dropper cap after each use. Dosage is based on your medical condition and response to treatment. Your doctor may direct you to use this medication more often at first, then use it less frequently as the infection improves. Follow your doctor's directions carefully. Tell your doctor if you are using other eye products (such as drops, ointments, artificial tears). Some ingredients in these products may interact with this medication and prevent it from working. Ask your doctor or pharmacist if you can use these eye products while using this medication and how long to wait before applying the other products. Use eye drops before eye ointments to allow the drops to enter the eye. Use this medication regularly in order to get the most benefit from it. To help you remember, use it at the same times each day. Continue using it for the full time prescribed, usually 7 to 10 days. Stopping the medication too soon may allow the bacteria to continue to grow, which may result in a return of the infection. Tell your doctor if your condition lasts or gets worse. Dosing & UsesAdultPediatric Dosage Forms & Strengthstrimethoprim/polymyxin B ophthalmic solution
Bacterial ConjunctivitisIndicated in the treatment of surface ocular bacterial infections, including acute bacterial conjunctivitis and blepharoconjunctivitis Instill 1 gtt in affected eye(s) q3hr for 7-10 days; not to exceed 6 doses/day Dosage Forms & Strengthstrimethoprim/polymyxin B ophthalmic solution
Bacterial ConjunctivitisIndicated in the treatment of surface ocular bacterial infections, including acute bacterial conjunctivitis and blepharoconjunctivitis <2 months: Safety and efficacy not established ≥2 years: Instill 1 gtt in affected eye(s) q3hr for 7-10 days; not to exceed 6 doses/day Adverse EffectsFrequency Not DefinedLocal irritation consisting of increased redness, burning, stinging, and/or itching Hypersensitivity reactions consisting of lid edema, itching, increased redness, tearing, and/or circumocular rash WarningsContraindicationsHypersensitivity CautionsNot for injection into the eye Not indicated for prophylaxis or treatment of ophthalmia neonatorum Prolonged use may result in overgrowth of nonsusceptible organisms Avoid contaminating applicator tip with material from the eye, fingers, or other source If redness, irritation, swelling or pain persists or increases, discontinue use immediately and seek medical attention Advise patient to not to wear contact lenses with active signs and symptoms of ocular bacterial infections or while using antibacterial eyedrops Pregnancy & LactationPregnancy Category: C Lactation: Unknown whether distributed in breast milk Pregnancy CategoriesA: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk. B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk. C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done. D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk. X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist. NA: Information not available. PharmacologyMechanism of ActionPolymyxin B: Bactericidal; causes leakage of bacterial membrane by binding to phospholipids Trimethoprim: Bactericidal; blocks production of tetrahydrofolic acid from dihydrofolic acid by binding to and reversibly inhibiting the enzyme dihydrofolate reductas Indicated for ocular infections caused by susceptible strains of the following microorganisms: Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus viridans, Haemophilus influenzae, and Pseudomonas aeruginosa ImagesNo images available for this drug. Patient HandoutA Patient Handout is not currently available for this monograph. FormularyFormularyPatient Discounts Adding plans allows you to compare formulary status to other drugs in the same class. To view formulary information first create a list of plans. Your list will be saved and can be edited at any time. Adding plans allows you to:
The above information is provided for general informational and educational purposes only. Individual plans may vary and formulary information changes. Contact the applicable plan provider for the most current information. View explanations for tiers and restrictions
Non-Medicare Plans Medicare Plans From: To: The recipient will receive more details and instructions to access this offer. By clicking send, you acknowledge that you have permission to email the recipient with this information. From: To: The recipient will receive more details and instructions to access this offer. By clicking send, you acknowledge that you have permission to email the recipient with this information. Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature. |